FindTrial
Sign In

Effectiveness of nutritional intervention to management Systemic Arterial Hypertension in Primary Health Care

Nutritional intervention to control Systemic Arterial Hypertension in Primary Health Care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5hvgtky
Enrollment
Unknown
Registered
2021-12-15
Start date
2022-01-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Participants will be randomized into Intervention Group and Control Group. Intervention Group: 128 individuals diagnosed with systemic arterial hypertension will receive individual and collective nutr
SP6.026

Sponsors

Universidade Federal de Ouro Preto
Lead Sponsor
Universidade Federal de Minas Gerais
Collaborator

Eligibility

Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: Both sexes; over 20 years old

Exclusion criteria

Exclusion criteria: Volunteers with cardiovascular disease, angina, heart attack, heart failure, atherosclerosis, peripheral vascular disease, ischemic cerebrovascular disease, chronic liver, kidney or infectious diseases evaluated by medical history; 10% change in body weight two months prior to the study; use of anti-inflammatory drugs; women on exogenous ovarian hormone replacement, pregnancy or breastfeeding; people with special needs; Alzheimer's disease, dementia or life expectancy shorter than study duration; cognitive difficulties.

Design outcomes

Primary

MeasureTime frame
Evaluate the reduction in blood pressure values ??of PHC (Primary Health Care) users with SAH (Systemic Arterial Hypertension) in Ouro Preto, Minas Gerais, verified by the method of measuring blood pressure using the sphygmomanometer instrument at the beginning of the study and at the end of the study. Blood pressure is expected to decrease to values ??close to 120 mmHg for systolic pressure and 80 mmHg for diastolic pressure.—

Secondary

MeasureTime frame
It is expected to find a 5% reduction in the Framingham risk score for cardiovascular diseases when compared to the values ??measured at the beginning of the study. We will observe a reduction in the consumption of ultra-processed foods in the daily diet, when compared to the amount verified at the beginning of the study and at the end of the study. A reduction of CRP (C-reactive protein), IL-6 (interleukin 6) and CRP and microalbuminuria by 10% is expected when compared to the initial value, based on the difference between hyper and normotensive individuals for CRP.—

Countries

Brazil

Contacts

Public ContactAnabele Santos
anabelepires@gmail.com+55-031-35591814

Outcome results

None listed

Source: REBEC (via WHO ICTRP)